WO2006108491A1 - Improved process for preparing oxazole nitriles - Google Patents
Improved process for preparing oxazole nitriles Download PDFInfo
- Publication number
- WO2006108491A1 WO2006108491A1 PCT/EP2006/002509 EP2006002509W WO2006108491A1 WO 2006108491 A1 WO2006108491 A1 WO 2006108491A1 EP 2006002509 W EP2006002509 W EP 2006002509W WO 2006108491 A1 WO2006108491 A1 WO 2006108491A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oxazole
- formula
- chloride
- phase
- nitriles
- Prior art date
Links
- -1 oxazole nitriles Chemical class 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- GIQQAQFTVJTULV-UHFFFAOYSA-N 1,3-oxazol-3-ium;chloride Chemical compound Cl.C1=COC=N1 GIQQAQFTVJTULV-UHFFFAOYSA-N 0.000 claims abstract description 19
- 125000003118 aryl group Chemical group 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 9
- UUAXDPHPSHEGQQ-UHFFFAOYSA-N 1,3-oxazole-2-carbonitrile Chemical compound N#CC1=NC=CO1 UUAXDPHPSHEGQQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- CQHYICHMGNSGQH-UHFFFAOYSA-N 1,3-oxazole-2-carboxylic acid Chemical class OC(=O)C1=NC=CO1 CQHYICHMGNSGQH-UHFFFAOYSA-N 0.000 claims description 4
- ZHKFCGUCHAGTKP-UHFFFAOYSA-N 3-oxido-1,3-oxazol-3-ium Chemical compound [O-][N+]=1C=COC=1 ZHKFCGUCHAGTKP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910019213 POCl3 Inorganic materials 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000005191 phase separation Methods 0.000 claims description 3
- 150000003242 quaternary ammonium salts Chemical group 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 150000004714 phosphonium salts Chemical group 0.000 claims description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- IPILPUZVTYHGIL-UHFFFAOYSA-M tributyl(methyl)azanium;chloride Chemical compound [Cl-].CCCC[N+](C)(CCCC)CCCC IPILPUZVTYHGIL-UHFFFAOYSA-M 0.000 description 3
- RGPUSZZTRKTMNA-UHFFFAOYSA-N 1-benzofuran-7-carbaldehyde Chemical compound O=CC1=CC=CC2=C1OC=C2 RGPUSZZTRKTMNA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical class [H]O* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 0 *c([o]1)c(CCl)nc1[Al] Chemical compound *c([o]1)c(CCl)nc1[Al] 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- ONGPDHWUKNYNRF-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetonitrile Chemical compound N#CCC1=C(C)OC(C=2C=CC=CC=2)=N1 ONGPDHWUKNYNRF-UHFFFAOYSA-N 0.000 description 1
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000008422 chlorobenzenes Chemical class 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JORQDGTZGKHEEO-UHFFFAOYSA-N lithium cyanide Chemical compound [Li+].N#[C-] JORQDGTZGKHEEO-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000006682 monohaloalkyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000003408 phase transfer catalysis Methods 0.000 description 1
- 125000006684 polyhaloalkyl group Polymers 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 102200073741 rs121909602 Human genes 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Definitions
- Oxazole nitriles such as, for instance, 2- (5-methyl-2- phenyl-1, 3-oxazol-4-yl) acetonitrile, are valuable intermediates in the synthesis of pharmaceuticals which are employed for example for the prophylaxis and/or treatment of diabetes II .
- the present invention accordingly relates to an improved process for preparing oxazole nitriles of the formula
- Oxazole nitriles of the formula (I) are prepared by the process of the invention.
- Ar is aryl or heteroaryl and Rl is H or alkyl .
- Aryl and heteroaryl mean in this connection aromatic compounds which preferably have 4 to 20 C atoms.
- the heteroaryl compounds additionally have 1 to 3 heteroatoms from the group of 0, N or S .
- Possibilities in this connection are monocyclic or polycyclic aromatic groups to which further rings (cycloalkyl, cycloheteroalkyl or heteroaryl) may be fused where appropriate .
- aromatic compounds examples include phenyl, naphthyl, cyclopentadienyl, indenyl , fluorenyl, indanyl, tetralinyl, pyrrolyl, furyl, thienyl, pyridyl, pyrimidinyl, indolyl, cumaronyl, quinolinyl, chromenyl , chromanyl, etc.
- aryl means phenyl or naphthyl and heteroaryl pyridyl .
- the aryl and heteroaryl radicals may moreover be optionally substituted one or more times.
- suitable substituents are alkyl, preferably Ci-C 3 -alkyl, alkoxy, preferably Ci-C 6 -alkoxy, halogen such as, for instance, chlorine, bromine or fluorine, mono- or polyhaloalkyl , mono- or polyhaloalkoxy, alkenyl , preferably C 2 -C 8 -alkenyl, optionally substituted phenyl, optionally substituted amine, hydroxy, nitro, carboxyl, carboxylic ester, etc.
- the aryl or heteroaryl radical is preferably unsubstituted or substituted once or twice by hydroxy, Ci-C 4 -alkyl, C 1 -C 4 -alkoxy, chlorine, trifluoromethyl or phenyl .
- Rl is H or alkyl, where alkyl means saturated or mono- or polyunsaturated, linear, branched or cyclic hydrocarbon chains having 1 to 20 C atoms, preferably having 1 to 8 C atoms. Examples thereof are methyl, ethyl, i-propyl, tert-butyl, cyclohexyl, propenyl, etc.
- the inventive preparation of the oxazole nitriles of the formula (I) starts from the corresponding oxazole chloride of the formula (II) .
- Suitable oxazole chlorides can be prepared as in the prior art as described, for instance, in Chem. Pharm. Bull., 1971, 19, pp. 2050; J. Med. Chem., 1996, 39, pp. 237-245; J. Med. Chem., 2000, 43, p. 995-1010, US 5468760, US 5480896, WO 03/043985, etc.
- the inventive reaction of the oxazole chlorides of the formula (II) to give the desired oxazole nitriles of the formula (I) takes place in a suitable solvent with an alkali metal cyanide in the presence of a phase- transfer catalyst .
- Suitable solvents for the inventive process are aromatic hydrocarbons, which may be optionally halogenated, such as, for instance, toluene, xylenes, chlorobenzenes, etc., or mixtures thereof with water.
- aromatic hydrocarbons which may be optionally halogenated, such as, for instance, toluene, xylenes, chlorobenzenes, etc., or mixtures thereof with water.
- a mixture of toluene and water is preferably employed as solvent .
- alkali metal cyanide Suitable examples of alkali metal cyanide are NaCN, LiCN, KCN, etc.
- the cyanide is in this case employed in at least the equivalent amount or in an excess relative to the oxazole chloride.
- the cyanide is preferably used in an amount of from 1.0 to 2.5 mol per mol of oxazole chloride and particularly preferably from 1.1 to 1.5 mol per mol of oxazole chloride .
- Suitable phase-transfer catalysts are quaternary phosphonium salts such as, for instance, (alkyl) 4 P + Hal " , (aryl) 4 P + Hal ⁇ , alkylaryl-P + HaI " , etc. or quaternary ammonium salts such as, for instance, tetraalkylammonium halides, tetraarylammonium halides, alkylarylammonium halides or cyanides, etc., which are described for example in CM. Starks, CL. Liotta, M. C. Halpern, Phase Transfer Catalysis; Chapman & Hall; New York, 1994.
- Halide means in this case preferably bromide or chloride.
- the tetraalkyl moiety consists of four alkyl groups, which may be identical or different, and comprise 1 to 16 C atoms.
- the aryl moiety may be for example phenyl or benzyl .
- Quaternary ammonium salts are preferably employed.
- phase-transfer catalysts examples include tetrabutylammonium bromide (TBAB) , tributylmethyl- ammonium chloride (TBMAC) , trimethylbenzylammonium chloride, etc.
- phase-transfer catalyst is employed in the inventive reaction in an amount of from 0.001 to 0.1 mol per mol of oxazole chloride. An amount of from 0.01 to 0.05 mol per mol of oxazole chloride is preferred.
- the reaction temperature is 50 to 120 0 C, preferably 75 to 90 0 C.
- reagents oxazole chloride, solvent, cyanide, phase-transfer catalyst
- the cyanide can also be added last, at the desired reaction temperature.
- the reaction mixture is cooled to a temperature of from 5 to 30 0 C, preferably to 15 to 25°C, and an aqueous base such as, for instance, a dilute Na 2 CO 3 or NaHCO 3 solution is added and, after phase separation, the organic phase is, where appropriate after extraction one or more times with the aqueous base, concentrated.
- suitable solvents for this are diisopropyl ether, tert-butyl methyl ether, methanol, etc.
- Oxazole nitriles of the formula (I) are prepared in higher yields compared with the prior art, and in high purity, from easily obtainable precursors in a simple manner which is easy to achieve industrially.
- Ar is aryl or heteroaryl
- Rl is H or alkyl
- R2 is alkyl or aryl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
An improved process for preparing oxazole nitriles of formula (I) in which Ar is aryl or heteroaryl and Rl is H or alkyl , which comprises reacting a corresponding oxazole chloride of formula (II) in which Ar and Rl are as defined above, in a solvent with an alkali metal cyanide in the presence of a phase-transfer catalyst to give the desired oxazole nitrile of formula (I) .
Description
Improved process for preparing oxazole nitriles
Oxazole nitriles such as, for instance, 2- (5-methyl-2- phenyl-1, 3-oxazol-4-yl) acetonitrile, are valuable intermediates in the synthesis of pharmaceuticals which are employed for example for the prophylaxis and/or treatment of diabetes II .
The use of such oxazole nitriles for preparing active pharmaceutical ingredients is disclosed for example in US 6,673,815. In Example 4 of the US patent, 2- (5- πiethyl-2 -phenyl- 1, 3-oxazol-4-yl) acetonitrile is obtained in a yield of 37% from the corresponding chloride by reaction with NaCN in DMSO. The chloride is in this case obtained according to Malamas et al . , J. Med. Chem. 39 (1) , 1996; 237-245, by reacting the corresponding benzaldehyde with 2 , 3-butanedione monoxime and subsequent deoxygenation with phosphorus oxychloride . In WO 02/092084 too, the corresponding chloride is reacted with NaCN in DMSO to give the nitrile. Once again, the yield is very low, not exceeding 50%. According to J. Med. Chem. 2001, 44, pp. 2061-2064, the chloride is reacted with KCN in the presence of KI in DMF to give the desired nitrile. The disadvantage in this case is the use of the costly auxiliary reagent KI.
A further possibility for preparing the nitriles is, according to US 6,673,815, reaction of the corresponding alcohol in accordance with the reference Aesa et al . , Synth. Commun. 1996, 26(5), 909-914 with acetone cyanohydrin in the presence of triphenylphosphine-diethyl azodicarboxylate .
It was an object of the present invention to find an improved process for preparing oxazole nitriles which starts from easily and inexpensively obtainable starting materials, which enables reaction in an efficient and industrially achievable manner and easy
purification of the reaction mixture, which affords the desired oxazole nitrile in higher yields.
The present invention accordingly relates to an improved process for preparing oxazole nitriles of the formula
in which Ar is aryl or heteroaryl and Rl is H or alkyl, which comprises reacting a corresponding oxazole chloride of the formula
in which Ar and Rl are as defined above, in a solvent with an alkali metal cyanide in the presence of a phase-transfer catalyst to give the desired oxazole nitrile of the formula (I) .
Oxazole nitriles of the formula (I) are prepared by the process of the invention.
In the formula (I) Ar is aryl or heteroaryl and Rl is H or alkyl . Aryl and heteroaryl mean in this connection aromatic compounds which preferably have 4 to 20 C atoms. The heteroaryl compounds additionally have 1 to 3 heteroatoms from the group of 0, N or S . Possibilities in this connection are monocyclic or polycyclic aromatic groups to which further rings (cycloalkyl, cycloheteroalkyl or heteroaryl) may be fused where appropriate .
Examples of such aromatic compounds are phenyl, naphthyl, cyclopentadienyl, indenyl , fluorenyl, indanyl, tetralinyl, pyrrolyl, furyl, thienyl, pyridyl, pyrimidinyl, indolyl, cumaronyl, quinolinyl, chromenyl , chromanyl, etc.
Preferably aryl means phenyl or naphthyl and heteroaryl pyridyl .
The aryl and heteroaryl radicals may moreover be optionally substituted one or more times. Examples of suitable substituents are alkyl, preferably Ci-C3-alkyl, alkoxy, preferably Ci-C6-alkoxy, halogen such as, for instance, chlorine, bromine or fluorine, mono- or polyhaloalkyl , mono- or polyhaloalkoxy, alkenyl , preferably C2-C8-alkenyl, optionally substituted phenyl, optionally substituted amine, hydroxy, nitro, carboxyl, carboxylic ester, etc.
The aryl or heteroaryl radical is preferably unsubstituted or substituted once or twice by hydroxy, Ci-C4-alkyl, C1-C4-alkoxy, chlorine, trifluoromethyl or phenyl .
Rl is H or alkyl, where alkyl means saturated or mono- or polyunsaturated, linear, branched or cyclic hydrocarbon chains having 1 to 20 C atoms, preferably having 1 to 8 C atoms. Examples thereof are methyl, ethyl, i-propyl, tert-butyl, cyclohexyl, propenyl, etc.
The inventive preparation of the oxazole nitriles of the formula (I) starts from the corresponding oxazole chloride of the formula (II) .
Ar and Rl in formula (II) are as defined above.
Suitable oxazole chlorides can be prepared as in the prior art as described, for instance, in Chem. Pharm. Bull., 1971, 19, pp. 2050; J. Med. Chem., 1996, 39, pp. 237-245; J. Med. Chem., 2000, 43, p. 995-1010, US 5468760, US 5480896, WO 03/043985, etc. It is particularly advantageous to purify the oxazole chloride, after the reaction of the corresponding
oxazole N-oxide with POCl3 as in the prior art, by- extraction with water and, where appropriate, recrystallization in methanol or a methanol/water mixture, because the purity of the product can be increased considerably thereby in an efficient and industrially achievable manner.
The inventive reaction of the oxazole chlorides of the formula (II) to give the desired oxazole nitriles of the formula (I) takes place in a suitable solvent with an alkali metal cyanide in the presence of a phase- transfer catalyst .
Suitable solvents for the inventive process are aromatic hydrocarbons, which may be optionally halogenated, such as, for instance, toluene, xylenes, chlorobenzenes, etc., or mixtures thereof with water. A mixture of toluene and water is preferably employed as solvent .
Suitable examples of alkali metal cyanide are NaCN, LiCN, KCN, etc.
The cyanide is in this case employed in at least the equivalent amount or in an excess relative to the oxazole chloride.
The cyanide is preferably used in an amount of from 1.0 to 2.5 mol per mol of oxazole chloride and particularly preferably from 1.1 to 1.5 mol per mol of oxazole chloride .
Suitable phase-transfer catalysts are quaternary phosphonium salts such as, for instance, (alkyl) 4P+Hal", (aryl) 4P+Hal~, alkylaryl-P+HaI", etc. or quaternary ammonium salts such as, for instance, tetraalkylammonium halides, tetraarylammonium halides, alkylarylammonium halides or cyanides, etc., which are described for example in CM. Starks, CL. Liotta, M. C. Halpern, Phase Transfer Catalysis; Chapman & Hall; New York, 1994.
Halide means in this case preferably bromide or chloride. The tetraalkyl moiety consists of four alkyl groups, which may be identical or different, and comprise 1 to 16 C atoms. The aryl moiety may be for example phenyl or benzyl .
Quaternary ammonium salts are preferably employed.
Examples of suitable phase-transfer catalysts are tetrabutylammonium bromide (TBAB) , tributylmethyl- ammonium chloride (TBMAC) , trimethylbenzylammonium chloride, etc.
The phase-transfer catalyst is employed in the inventive reaction in an amount of from 0.001 to 0.1 mol per mol of oxazole chloride. An amount of from 0.01 to 0.05 mol per mol of oxazole chloride is preferred.
The reaction temperature is 50 to 1200C, preferably 75 to 900C.
To carry out the process, preferably all the reagents (oxazole chloride, solvent, cyanide, phase-transfer catalyst) are introduced simultaneously and then heated to the desired temperature, preferably while stirring. Alternatively, the cyanide can also be added last, at the desired reaction temperature. After the reaction is complete, the reaction mixture is cooled to a temperature of from 5 to 300C, preferably to 15 to 25°C, and an aqueous base such as, for instance, a dilute Na2CO3 or NaHCO3 solution is added and, after phase separation, the organic phase is, where appropriate after extraction one or more times with the aqueous base, concentrated. The remaining residue is recrystallized where appropriate in a suitable solvent. Examples of suitable solvents for this are diisopropyl ether, tert-butyl methyl ether, methanol, etc.
Oxazole nitriles of the formula (I) are prepared in higher yields compared with the prior art, and in high
purity, from easily obtainable precursors in a simple manner which is easy to achieve industrially.
The oxazole nitriles of the formula (I) which are prepared according to the invention are moreover outstandingly suitable for further reaction to give the corresponding oxazole carboxylic esters of the formula
in which Ar is aryl or heteroaryl, Rl is H or alkyl and R2 is alkyl or aryl, for example by converting the appropriate oxazole nitrile into the desired oxazole carboxylic esters in the presence of a mineral acid and of an alcohol of the formula R20H and subsequent hydrolysis with water.
Example 1: Preparation of 2- (5-methyl-2 -phenyl-I73- oxazol-4-yl) acetonitrile
a) Preparation of the oxazole chloride
1465 g (13.8 mol) of benzaldehyde, 1244 g (12.3 mol) of 2,3-butanedione monoxime and 4.8 1 of cone, acetic acid were mixed and this mixture was cooled to 40C while stirring. Then, over the course of 100 min, 1500 g (41.1 mol) of HCl gas were passed in at an internal temperature of 4-120C. The reaction mixture was stirred at the same temperature for 1 h and then, at 10-200C, 21 1 of t-butyl methyl ether (MTBE) were added over the course of 45 min. The MTBE addition was initially exothermic. The mixture was then stirred at 50C for a further 30 min and subsequently the resulting solid was filtered off. The solid was washed with MTBE and dried in vacuo at 5O0C.
Yield: 2498 g of oxazole N-oxide (11.07 mol, 90%).
2220 g of oxazole N-oxide were suspended in 19.9 1 of methylene chloride, and this mixture was cooled to 5°C. Then, over the course of 15 min, 2837 g (18.5 mol) of POCl3 were added at an internal temperature of 5-70C. Stirring at 5-70C for 3.0 min was followed by slow warming to 400C and stirring at this temperature for 3 h. After cooling to 50C, 34.7 1 of water were added over the course of 2 h. The phases were separated and the organic phase was extracted with 17.3 1 of water.
The organic phase was concentrated in vacuo, and the residue was recrystallized from methanol/water
(14.4 1/14.4 1) and washed with 10 1 of water. Filtration and drying resulted in 1940 g (9.35 mol, 95%) of the oxazole chloride.
b) Reaction of the oxazole chloride
1634 g (7.87 mol) of oxazole chloride, 463 g (9.44 mol) of NaCN, 28 g (0.119 mol) of tributylmethylammonium chloride, 4.9 1 of toluene and 0.24 1 of H2O were introduced into the reactor, and this mixture was heated at 80-85°C while stirring vigorously for 6 h. After the reaction mixture had cooled to 200C, dilute aqueous Na2CO3 solution was added and, after phase separation, the organic phase was extracted twice with dilute aqueous Na2CO3 solution. The residue after concentration of the organic phase in vacuo was dissolved in diisopropyl ether, filtered through activated carbon and crystallized. 1435 g (7.24 mol, 92%) of the oxazole nitrile were obtained.
Claims
1. An improved process for preparing oxazole nitriles of the formula
in which Ar is aryl or heteroaryl and Rl is H or alkyl , which comprises reacting a corresponding oxazole chloride of the formula
in which Ar and Rl are as defined above, in a solvent with an alkali metal cyanide in the presence of a phase-transfer catalyst to give the desired oxazole nitrile of the formula (I) .
2. The process as claimed in claim 1, wherein the reaction takes place in a solvent from the group of optionally halogenated aromatic hydrocarbons or in a mixture thereof with water.
3. The process as claimed in either of claims 1 or 2 , wherein the cyanide is employed in an amount of from 1.0 to 2.5 mol per mol of oxazole chloride .
4. The process as claimed in any of claims 1 to 3 , wherein a quaternary phosphonium salt or a quaternary ammonium salt is employed as phase- transfer catalyst .
5. The process as claimed in any of claims 1 to 4, wherein the phase-transfer catalyst is employed in an amount of from 0.001 to 0.1 mol per mol of oxazole chloride .
6. The process as claimed in any of claims 1 to 5, wherein the reaction is carried out at from 50 to 12O0C.
7. The process as claimed in any of claims 1 to 6, wherein the oxazole nitrile of the formula (I) is isolated by adding, after the reaction has taken place, an aqueous base to the reaction mixture, after which a phase separation takes place, the organic phase is, where appropriate after extraction with the aqueous base, concentrated, and the remaining residue is recrystallized where appropriate.
8. The process as claimed in any of claims 1 to 7, wherein the chloride of the formula (II) employed is prepared by reacting the corresponding oxazole N-oxide with POCl3, extracting with water and, where appropriate, subsequently recrystallizing in methanol or a methanol/water mixture.
9. The use of oxazole nitriles of the formula (I) prepared as claimed in any of claims 1 to 8 for preparing oxazole carboxylic esters of the formula
in which Ar is aryl or heteroaryl, Rl is H or alkyl and R2 is alkyl or aryl .
10. The use as claimed in claim 9, wherein an appropriate oxazole nitrile of the formula (I) is converted into the desired oxazole carboxylic ester of the formula (II) in the presence of a mineral acid and of an alcohol of the formula R2OH and subsequent hydrolysis with water.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ATA598/2005 | 2005-04-11 | ||
AT5982005 | 2005-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006108491A1 true WO2006108491A1 (en) | 2006-10-19 |
Family
ID=36570918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/002509 WO2006108491A1 (en) | 2005-04-11 | 2006-03-18 | Improved process for preparing oxazole nitriles |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006108491A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012153331A2 (en) | 2011-05-09 | 2012-11-15 | Topical Therapeutic Agent (Tta) Ltd. | Nitric oxide-sequestering topical formulations |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1139940A (en) * | 1966-09-30 | 1969-01-15 | Ici Ltd | Oxazole derivatives |
US4661610A (en) * | 1985-07-31 | 1987-04-28 | Basf Aktiengesellschaft | Preparation of veratryl cyanide |
WO2002018355A1 (en) * | 2000-08-23 | 2002-03-07 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
US20030055265A1 (en) * | 2001-05-15 | 2003-03-20 | Alfred Binggeli | Oxazole derivatives |
-
2006
- 2006-03-18 WO PCT/EP2006/002509 patent/WO2006108491A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1139940A (en) * | 1966-09-30 | 1969-01-15 | Ici Ltd | Oxazole derivatives |
US4661610A (en) * | 1985-07-31 | 1987-04-28 | Basf Aktiengesellschaft | Preparation of veratryl cyanide |
WO2002018355A1 (en) * | 2000-08-23 | 2002-03-07 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
US20030055265A1 (en) * | 2001-05-15 | 2003-03-20 | Alfred Binggeli | Oxazole derivatives |
Non-Patent Citations (1)
Title |
---|
BROOKS D A ET AL: "Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2- aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: a new class of dual PPARalpha/gamma agonists", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 44, no. 13, 21 June 2001 (2001-06-21), pages 2061 - 2064, XP002184099, ISSN: 0022-2623 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012153331A2 (en) | 2011-05-09 | 2012-11-15 | Topical Therapeutic Agent (Tta) Ltd. | Nitric oxide-sequestering topical formulations |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2593752C1 (en) | Compounds applicable for synthesis of benzamide compounds | |
Guchhait et al. | One-pot preparation of isocyanides from amines and their multicomponent reactions: crucial role of dehydrating agent and base | |
KR101472686B1 (en) | Method for preparation of benzimidazole derivatives | |
EA036663B1 (en) | Method for preparing azoxystrobin | |
RU2650110C2 (en) | Processes for synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds | |
CN110256451B (en) | Synthetic method of benzofuro [2,3-b ] quinoline derivative | |
CN115197261B (en) | Synthesis method of oxadiazine boron derivative | |
WO2006108491A1 (en) | Improved process for preparing oxazole nitriles | |
CN101475536A (en) | Polysubstituted S-DACO derivative, synthesizing method and use thereof | |
WO2017081702A2 (en) | A process for preparation of enzalutamide | |
JP5033933B2 (en) | Process for producing N-substituted-2-amino-4- (hydroxymethylphosphinyl) -2-butenoic acid | |
KR20190049883A (en) | Method for producing phenylalanine compound | |
CN107954960B (en) | A kind of synthetic method of 1,3-dihydroisobenzofuran compounds | |
CN112661668A (en) | N-substituted amide compound and preparation method thereof | |
CN112979632A (en) | Synthesis method of 4-hydroxy-1, 3-thiazine-2-thioketone compound | |
JP5334435B2 (en) | Method for producing optically active aminoacetal derivative | |
CN110746337B (en) | Synthesis method of 1-methyl-2-cyano-3-aliphatic substituted azole compound | |
CN100389110C (en) | A kind of method for preparing aromatic ring substituted isoxazoline compounds | |
JP5142241B2 (en) | Method for producing nicotinic acid ester compound | |
JP4032861B2 (en) | Process for producing β-oxonitrile derivative or alkali metal salt thereof | |
MXPA02001248A (en) | Process for the preparation of acylated 1,3-dicarbonyl compounds. | |
Kim et al. | Organozinc reagents for facile synthetic route to Diflunisal, Fenbufen and Felbinac | |
WO2007086559A1 (en) | Method for producing tetrahydropyran compound | |
JP4663105B2 (en) | Method for producing 2-sulfonyl-4-oxypyridine derivative | |
KR101354175B1 (en) | Method of preparing methyl (e)-2-(3-methoxy)acrylate from 2-(3,3-demethoxy)propanoate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06707606 Country of ref document: EP Kind code of ref document: A1 |